Comparison of the effect of fluoxetine and citalopram on motor recovery after ischemic stroke, single-blind clinical trial

Phase 3

Recruiting

• Conditions: I63.9; Ischemic stroke.; Cerebral infarction, unspecified

• Registration Number: IRCT20210307050617N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Age over 18 years
Hemiparesis or hemiplegia after the first ischemic stroke in 24 hours
A score greater than 2 NIHSS scale motion items

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate the rate of improvement in motor function after receiving the drug after one, two and three months. Timepoint: The patient's motor function is measured every month. The study time on each case is 90 days. Method of measurement: Using the NIHSS scale motion item.